Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Hyejin Noh
CONTACT
Lead
Kyowa Kirin Co., Ltd.
This post-marketing surveillance (PMS) is designed as an all-case investigation in accordance with the Korean Ministry of Food and Drug Safety (MFDS) re-examination requirements. It targets adult patients with mycosis fungoides (MF) or Sézary syndrome (SS) who have received at least one prior systemic therapy and are treated with mogamulizumab (POTELIGEO® Injection 20 mg) under the approved indication in Korea. Primary Objective: To assess the safety of mogamulizumab for patients treated under the approved indication in Korea. Secondary Objective: To assess the effectiveness of mogamulizumab for patients treated under the approved indication in Korea. Exploratory Objective: To perform additional subgroup and exploratory analyses of effectiveness, including evaluation in special populations such as elderly patients, patients with renal or hepatic impairment, and those with a history of hematopoietic stem cell transplantation, treated under the approved indication in Korea
Age
19–any
Sex
ALL
Healthy volunteers
Not accepted
